Roche Boehringer Mannheim Diagnostics Overview

  • Year Founded
  • 1859

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 6

Roche Boehringer Mannheim Diagnostics General Information

Description

Manufacturer of drugs and diagnostic products in Germany.

Contact Information

Formerly Known As
Boehringer Mannheim
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Stuttgart
  • Germany
Primary Industry
Diagnostic Equipment
Other Industries
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • Stuttgart
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Roche Boehringer Mannheim Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Roche Boehringer Mannheim Diagnostics‘s full profile, request access.

Request a free trial

Roche Boehringer Mannheim Diagnostics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Roche Boehringer Mannheim Diagnostics‘s full profile, request access.

Request a free trial

Roche Boehringer Mannheim Diagnostics Investments & Acquisitions (6)

Roche Boehringer Mannheim Diagnostics’s most recent deal was a PIPE with Genemedicine (Biotechnology) for . The deal was made on 10-Feb-1998.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Genemedicine (Biotechnology) 10-Feb-1998 PIPE Biotechnology
Genemedicine (Biotechnology) 04-Feb-1997 PIPE Biotechnology
Genemedicine (Biotechnology) 06-Feb-1996 PIPE Biotechnology
MolMed 01-Jan-1996 Joint Venture Drug Discovery
LDA Systems 25-Apr-1994 Merger/Acquisition Consulting Services (B2B)
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Roche Boehringer Mannheim Diagnostics Exits (6)

Roche Boehringer Mannheim Diagnostics’s most recent exit was on 10-Feb-1998 from Genemedicine (Biotechnology). The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Genemedicine (Biotechnology) 10-Feb-1998 Completed
Genemedicine (Biotechnology) 04-Feb-1997 Completed
Genemedicine (Biotechnology) 06-Feb-1996 Completed
MolMed 01-Jan-1996 Completed
  • 2 buyers
LDA Systems 25-Apr-1994 Merger/Acquisition Completed
You’re viewing 5 of 6 exits. Get the full list »

Roche Boehringer Mannheim Diagnostics FAQs

  • When was Roche Boehringer Mannheim Diagnostics founded?

    Roche Boehringer Mannheim Diagnostics was founded in 1859.

  • Where is Roche Boehringer Mannheim Diagnostics headquartered?

    Roche Boehringer Mannheim Diagnostics is headquartered in Stuttgart, Germany.

  • What industry is Roche Boehringer Mannheim Diagnostics in?

    Roche Boehringer Mannheim Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Roche Boehringer Mannheim Diagnostics a private or public company?

    Roche Boehringer Mannheim Diagnostics is a Private company.

  • What is Roche Boehringer Mannheim Diagnostics’s current revenue?

    The current revenue for Roche Boehringer Mannheim Diagnostics is .

  • Who are Roche Boehringer Mannheim Diagnostics’s investors?

    Corange has invested in Roche Boehringer Mannheim Diagnostics.

  • When was Roche Boehringer Mannheim Diagnostics acquired?

    Roche Boehringer Mannheim Diagnostics was acquired on 26-May-1997.

  • Who acquired Roche Boehringer Mannheim Diagnostics?

    Roche Boehringer Mannheim Diagnostics was acquired by Roche.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process